Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-11-14
2006-11-14
Siew, Jeffrey (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S004000, C530S388800
Reexamination Certificate
active
07135301
ABSTRACT:
An antigen is shown to be associated with prostate cancer, and is useful for new methods and compositions for diagnosing or treating prostate cancer. This is particularly useful for individuals with prostate cancer who test negative for Prostate Specific Antigen. Additionally, this is useful for distinguishing between benign prostate disease and prostate cancer in a patient diagnosed or presenting with prostate dysfunction.
REFERENCES:
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 5227160 (1993-07-01), Nudelman et al.
patent: WO 97/03701 (1997-02-01), None
Tsuji et al. J. Exp. Med. 1988,168: 343-356.
Nudelman et al., J Biol Chem 1989, 264: 18719-18725).
Fundamental Immunology p. 242,William E. Paul, M.D. ed., 3d ed. 1993.
Nudelman et al. (JBC 1989; 264: 18719-18725).
Itai et al., “Differentiation-dependent Expression of 1 and Sialyl 1 Antigens in the Developing Lung of Human Embryos and in Lung Cancers,”Cancer Res. 50:7603-7611, Dec. 1, 1990.
Nudelman et al., “A Series of Disialogangliosides with Binary 2→3 Sialyllactosamine Structure, Defined by Monoclonal Antibody NUH2, Are Oncodevelopmentally Regulated Antigens,”J.Biol. Chem. 284(31): 18719-18725, Nov. 5, 1989.
Kannagi et al, “Quantitative and Qualitative Characterization of Human Cancer-associated Serum Glycoprotein Antigens Expressing Fucosyl or Sialyl-Fucosyl Type 2 Chain Polylactosamine,”Cancer Res. 46:2619-2626, 1986.
Laganà, A. et al., “Determination of serum total lipid and freeN-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of freeN-acetylneuraminic acid as tumour marker,”Clinica Chimica Acta 243:165-179, 1995.
Satoh, M. et al., “Glycolipid Expression in Prostatic Tissue and Analysis of the Antigen Recognized by Antiprostatic Monoclonal Antibody APG1,”Urol. Int. 48: 20-24, 1992.
Shiraishi, T. et al., “The glycosphingolipids of human prostate tissue,”Biochimica et Biohphysica Acta 961: 160-169, 1988.
Fetterolf Brandon
GlycoMimetics, Inc.
Seed IP Law Group PLLC
Siew Jeffrey
LandOfFree
Detection and treatment of prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection and treatment of prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and treatment of prostate cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3648335